Ticagrelor: An emerging oral antiplatelet agent. - Wikidata - wikimedia - TriplyDB

Ticagrelor: An emerging oral antiplatelet agent.

Ticagrelor: An emerging oral antiplatelet agent.

http://www.wikidata.org/entity/Q40359329

about

A new paradigm shift in antithrombotic therapy.Spontaneous hematoma in the setting of dual anti-platelet therapy with ticagrelor: A case report.

P2860

Q38155157-73888D15-71E4-45C1-92A6-1B159BA581A7 Q42214267-B81E82D6-E95E-449A-83B7-B4683D41C8DF

P2860

Ticagrelor: An emerging oral antiplatelet agent.

http://www.wikidata.org/entity/Q40359329

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

2013年论文

@zh

2013年论文

@zh-cn

name

Ticagrelor: An emerging oral antiplatelet agent.

@en

type

label

Ticagrelor: An emerging oral antiplatelet agent.

@en

prefLabel

Ticagrelor: An emerging oral antiplatelet agent.

@en

P1433

Q40359329-7BF05389-E2EF-46ED-BF64-19B6A8A911BE

P1476

Q40359329-75CE77A2-D587-4F1F-9222-8200803EAEA3

P2093

Q40359329-1906BE5D-C580-4591-B2B4-F5D4294C1EF1

Q40359329-7D5957DF-B780-4734-9CA5-79B4AB6B2971

Q40359329-FC02544D-29D3-4590-8A5A-965A6EBE2BE1

P2860

Q40359329-343E2BAB-9A8C-418D-B273-AFF1F000B758

Q40359329-42ADFCA8-F958-437A-8424-EB165BECD805

Q40359329-4705BCA4-F7ED-473B-AF67-22C2952D996F

Q40359329-808DD714-B167-4E2F-90B8-0AC6C7D4E27C

Q40359329-9B832211-4EA0-4E97-B4AF-545E16652705

Q40359329-9E664CD4-0C59-44CF-A582-C7A78B75078C

Q40359329-CEA57ABF-BA49-4E2A-9C67-8CD12A21584D

Q40359329-ED07DBBE-9F83-4F4F-AE45-7252CB9E1584

Q40359329-EEAF8CEC-D682-47F3-804B-77373341806F

P304

Q40359329-95F38547-F6E4-44ED-AF23-CCEEB9DE867A

P31

Q40359329-05021988-CEF9-4D95-AB31-9F1C2DE3B6F9

P356

Q40359329-1BEC3D37-DF19-450A-9C0A-F3DFF48C02F4

P433

Q40359329-97BA4B2A-751A-402C-98FB-B141FAB4412B

P478

Q40359329-C0AB1EF3-3372-448C-A253-332B75150143

P577

Q40359329-66DDAA92-2A98-41A6-88B4-73D3E73B556A

P698

Q40359329-3433640A-925B-476B-8DBE-059F5F98FB4A

P932

Q40359329-29E4DC43-24EF-4E25-B62A-C7BF386A37CD

P356

0976-500X.107698

P1433

Journal of Pharmacology & Pharmacotherapeutics

P1476

Ticagrelor: An emerging oral antiplatelet agent.

@en

P2093

Kanchan Gupta

http://www.w3.org/2001/XMLSchema#string

Sandeep Kaushal

http://www.w3.org/2001/XMLSchema#string

Shivani Juneja

http://www.w3.org/2001/XMLSchema#string

P2860

Ticagrelor: the evidence for its clinical potential as an oral antiplatelet treatment for the reduction of major adverse cardiac events in patients with acute coronary syndromes

Ticagrelor versus clopidogrel in patients with acute coronary syndromes

Novel antiplatelet agents in the prevention of cardiovascular complications--focus on ticagrelor.

Advances in antiplatelet therapy.

Critical appraisal of ticagrelor in the management of acute coronary syndrome

Ticagrelor: the first reversibly binding oral P2Y12 receptor antagonist

Ticagrelor: an investigational oral antiplatelet treatment for reduction of major adverse cardiac events in patients with acute coronary syndrome.

Ticagrelor: a novel reversible oral antiplatelet agent.

Emerging antiplatelet agents, differential pharmacology, and clinical utility.

P304

78-80

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4103/0976-500X.107698

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

4

http://www.w3.org/2001/XMLSchema#string

P577

2013-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23662033

http://www.w3.org/2001/XMLSchema#string

P932

3643352

http://www.w3.org/2001/XMLSchema#string